PL3202779T3 - Polopeptydy o długotrwałym działaniu oraz ich zastosowanie - Google Patents

Polopeptydy o długotrwałym działaniu oraz ich zastosowanie

Info

Publication number: PL3202779T3
Authority: PL; Poland
Prior art keywords: long; hgh polypeptides; acting hgh; acting; polypeptides
Prior art date: 2006-02-03

Application number

PL17161199T

Other languages

English (en)

Inventor

Fuad Fares

Udi Eyal Fima

Original Assignee

Opko Biologics Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-02-03

Filing date

2007-02-05

Publication date

2020-06-29

2007-02-05 Application filed by Opko Biologics Ltd. filed Critical Opko Biologics Ltd.

2020-06-29 Publication of PL3202779T3 publication Critical patent/PL3202779T3/pl

Links

229920001184 polypeptide Polymers 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Child & Adolescent Psychology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PL17161199T 2006-02-03 2007-02-05 Polopeptydy o długotrwałym działaniu oraz ich zastosowanie PL3202779T3 (pl)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US76476106P	2006-02-03	2006-02-03
PCT/US2007/003014 WO2007094985A2 (en)	2006-02-03	2007-02-05	Long-acting polypeptides and methods of producing and administering same
EP17161199.9A EP3202779B1 (en)	2006-02-03	2007-02-05	Long-acting hgh polypeptides and uses thereof
EP07749922.6A EP2001903B1 (en)	2006-02-03	2007-02-05	Long-acting polypeptides and methods of producing and administering same
EP14197286.9A EP2853536B1 (en)	2006-02-03	2007-02-05	Long-acting erythropoietin polypeptides and uses thereof
EP12179805.2A EP2532674B1 (en)	2006-02-03	2007-02-05	Long-acting polypeptides and methods of producing and administering same

Publications (1)

Publication Number	Publication Date
PL3202779T3 true PL3202779T3 (pl)	2020-06-29

Family

ID=38345655

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL12150722T PL2471807T3 (pl)	2006-02-03	2007-02-05	Długodziałające polipeptydy hormonu wzrostu oraz sposoby ich wytwarzania i stosowania
PL17161199T PL3202779T3 (pl)	2006-02-03	2007-02-05	Polopeptydy o długotrwałym działaniu oraz ich zastosowanie

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL12150722T PL2471807T3 (pl)	2006-02-03	2007-02-05	Długodziałające polipeptydy hormonu wzrostu oraz sposoby ich wytwarzania i stosowania

Country Status (16)

Country	Link
US (7)	US7553940B2 (pl)
EP (8)	EP2853536B1 (pl)
JP (5)	JP5905185B2 (pl)
KR (5)	KR101651977B1 (pl)
CN (3)	CN101595122B (pl)
AU (1)	AU2007215466C1 (pl)
CA (2)	CA2641342C (pl)
DK (3)	DK2471807T3 (pl)
ES (5)	ES2494792T3 (pl)
HK (1)	HK1205945A1 (pl)
HU (1)	HUE048307T2 (pl)
IL (5)	IL193198A (pl)
PL (2)	PL2471807T3 (pl)
PT (2)	PT2471807E (pl)
SI (3)	SI2471807T1 (pl)
WO (2)	WO2007092252A2 (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9453251B2 (en)	2002-10-08	2016-09-27	Pfenex Inc.	Expression of mammalian proteins in Pseudomonas fluorescens
WO2006014899A2 (en)	2004-07-26	2006-02-09	Dow Global Technologies Inc.	Process for improved protein expression by strain engineering
US9458444B2 (en)	2006-02-03	2016-10-04	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US10351615B2 (en) *	2006-02-03	2019-07-16	Opko Biologics Ltd.	Methods of treatment with long-acting growth hormone
US20150038413A1 (en)	2006-02-03	2015-02-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US8304386B2 (en) *	2006-02-03	2012-11-06	Prolor Biotech, Inc.	Long-acting growth hormone and methods of producing same
US8048849B2 (en)	2006-02-03	2011-11-01	Modigene, Inc.	Long-acting polypeptides and methods of producing same
US20140113860A1 (en)	2006-02-03	2014-04-24	Prolor Biotech Ltd.	Long-acting polypeptides and methods of producing and administering same
US7553940B2 (en) *	2006-02-03	2009-06-30	Modigene Inc	Long-acting EPO polypeptides and derivatives thereof and methods thereof
US8450269B2 (en)	2006-02-03	2013-05-28	Prolor Biotech Ltd.	Long-acting growth hormone and methods of producing same
US8476234B2 (en) *	2006-02-03	2013-07-02	Prolor Biotech Inc.	Long-acting coagulation factors and methods of producing same
US8048848B2 (en) *	2006-02-03	2011-11-01	Prolor Biotech Ltd.	Long-acting interferons and derivatives thereof and methods thereof
US8759292B2 (en)	2006-02-03	2014-06-24	Prolor Biotech, Llc	Long-acting coagulation factors and methods of producing same
US8946155B2 (en)	2006-02-03	2015-02-03	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US10221228B2 (en)	2006-02-03	2019-03-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US9249407B2 (en)	2006-02-03	2016-02-02	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
KR101248252B1 (ko)	2006-11-28	2013-03-27	한올바이오파마주식회사	변형된 에리스로포이에틴 폴리펩티드와 이의 치료용 용도
US9580719B2 (en)	2007-04-27	2017-02-28	Pfenex, Inc.	Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
KR101530395B1 (ko)	2007-04-27	2015-06-19	피페넥스 인크.	향상된 수율 및(또는) 품질로 이종 단백질을 발현하는 특정 균주를 동정하기 위해 미생물 숙주를 신속히 스크리닝하는 방법
US12203113B2 (en)	2009-07-09	2025-01-21	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US9663778B2 (en)	2009-07-09	2017-05-30	OPKO Biologies Ltd.	Long-acting coagulation factors and methods of producing same
AU2015201906B2 (en) *	2009-07-09	2017-07-13	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
KR102310704B1 (ko)	2012-02-14	2021-10-08	옵코 바이오로직스 리미티드	장기 작용 응고 인자들 및 이를 생산하는 방법들
JP2015520128A (ja) *	2012-04-19	2015-07-16	オプコバイオロジクスリミテッド	長時間作用性オキシントモジュリン変異体とその作製方法
CN114317505A (zh) *	2012-11-20	2022-04-12	奥普科生物制品有限公司	通过连接至促性腺激素羧基端肽来增加多肽的流体动力学体积的方法
CN103864913A (zh) *	2012-12-18	2014-06-18	联亚生技开发股份有限公司	重组蛋白
EP2968391A1 (en)	2013-03-13	2016-01-20	Moderna Therapeutics, Inc.	Long-lived polynucleotide molecules
US20150158926A1 (en) *	2013-10-21	2015-06-11	Opko Biologics, Ltd.	Long-acting polypeptides and methods of producing and administering same
US20150126444A1 (en) *	2013-10-21	2015-05-07	Opko Biologics, Ltd.	Long-acting polypeptides and methods of producing and administering same
TWI893324B (zh) *	2013-10-21	2025-08-11	以色列商歐科生物製品有限公司	長效型多肽及其生產和給藥的方法
US10287336B2 (en) *	2014-09-18	2019-05-14	AskGene Pharma, Inc.	Feline erythropoietin receptor agonists
CN105440138A (zh) *	2014-09-30	2016-03-30	复旦大学	一种长效内皮抑素融合蛋白的制备方法和用途
PL3230309T3 (pl)	2014-12-10	2023-08-28	Opko Biologics Ltd.	Sposoby wytwarzania długo działających polipeptydów hormonu wzrostu zmodyfikowanych ctp
JP7000153B2 (ja) *	2014-12-10	2022-01-19	オプコバイオロジクスリミテッド	長時間作用性ｃｔｐ修飾成長ホルモンポリペプチドを生成する方法
CA3228939A1 (en)	2015-06-19	2016-12-22	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
SG11201900279UA (en)	2016-07-11	2019-02-27	Opko Biologics Ltd	Long-acting coagulation factor vii and methods of producing same
US20180236031A1 (en) *	2017-02-10	2018-08-23	Vivibaba, Inc	Compositions and methods for recombinant nerve growth factor
CN114391020B (zh) *	2019-08-30	2025-01-21	辛太克斯股份公司	重组绒膜促性腺激素、制备工艺、药物组合物及其用途
WO2023081494A2 (en) *	2021-11-08	2023-05-11	Boston Medical Center Corporation	Nucleoside modified mrna and uses thereof
WO2025237276A1 (zh) *	2024-05-14	2025-11-20	北京剂泰医药科技有限公司	改进的mRNA分子

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US571212A (en)		1896-11-10		Hose-coupling
NL154600B (nl)	1971-02-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl)	1970-11-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl)	1970-12-28	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en)	1971-06-21	1975-08-26	Biological Developments	Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en)	1971-09-01	1974-12-10	W Dreyer	Immunological reagent and radioimmuno assay
US3867517A (en)	1971-12-21	1975-02-18	Abbott Lab	Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl)	1972-05-11	1983-06-01	Akzo Nv	Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en)	1973-03-12	1974-11-26	H Mcconnell	Process for assaying for biologically active molecules
US3935074A (en)	1973-12-17	1976-01-27	Syva Company	Antibody steric hindrance immunoassay with two antibodies
US3996345A (en)	1974-08-12	1976-12-07	Syva Company	Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en)	1974-09-19	1977-07-05	The Board Of Trustees Of Leland Stanford Junior University	Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en)	1975-11-13	1976-10-05	General Electric Company	Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en)	1976-10-26	1978-07-04	Corning Glass Works	Reverse sandwich immunoassay
US4879219A (en)	1980-09-19	1989-11-07	General Hospital Corporation	Immunoassay utilizing monoclonal high affinity IgM antibodies
JPS5781447A (en)	1980-11-11	1982-05-21	Toyo Jozo Co Ltd	Human chorionic gonadotropic hormone c-terminal fragment
US4853332A (en) *	1982-10-19	1989-08-01	Cetus Corporation	Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
US5011771A (en)	1984-04-12	1991-04-30	The General Hospital Corporation	Multiepitopic immunometric assay
DE3421468A1 (de)	1984-06-08	1985-12-19	Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim	Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US4666828A (en)	1984-08-15	1987-05-19	The General Hospital Corporation	Test for Huntington's disease
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US4801531A (en)	1985-04-17	1989-01-31	Biotechnology Research Partners, Ltd.	Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
DE122007000007I1 (de)	1986-04-09	2007-05-16	Genzyme Corp	Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
US5118666A (en)	1986-05-05	1992-06-02	The General Hospital Corporation	Insulinotropic hormone
US4873316A (en)	1987-06-23	1989-10-10	Biogen, Inc.	Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5272057A (en)	1988-10-14	1993-12-21	Georgetown University	Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5792460A (en) *	1989-02-21	1998-08-11	Washington University	Modified glycoprotein hormones having a CTP at the amino terminus
US5705478A (en)	1989-02-21	1998-01-06	Washington University	Covalently linked β subunits of the glycoprotein hormones as antagonists
CA2053864C (en) *	1989-02-21	2001-11-20	Irving Boime	Modified forms of reproductive hormones
US6225449B1 (en) *	1991-10-04	2001-05-01	Washington University	Hormone analogs with multiple CTP extensions
US5338835A (en)	1989-02-21	1994-08-16	Washington University	CTP-extended form of FSH
US5464764A (en)	1989-08-22	1995-11-07	University Of Utah Research Foundation	Positive-negative selection methods and vectors
US5192659A (en)	1989-08-25	1993-03-09	Genetype Ag	Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US7217689B1 (en)	1989-10-13	2007-05-15	Amgen Inc.	Glycosylation analogs of erythropoietin
US5126324A (en)	1990-06-07	1992-06-30	Genentech, Inc.	Method of enhancing growth in patients using combination therapy
US5238890A (en) *	1990-10-31	1993-08-24	Idemitsu Kosan Company Limited	Exhaust gas purifying catalyst and an exhaust gas purifying method using the catalyst
US6028177A (en)	1991-10-04	2000-02-22	Washington University	Methods of detecting single-chain forms of the glycoprotein hormone quartet
US5281521A (en)	1992-07-20	1994-01-25	The Trustees Of The University Of Pennsylvania	Modified avidin-biotin technique
CA2160800C (en)	1993-04-20	2010-06-01	Irving Boime	Ctp modified gonadotropic proteins
US6737515B2 (en)	1993-11-19	2004-05-18	Washington University	Follicle stimulating hormone-glycosylation analogs
US6238890B1 (en)	1994-02-18	2001-05-29	Washington University	Single chain forms of the glycoprotein hormone quartet
US5935924A (en)	1994-04-15	1999-08-10	Genentech, Inc.	Treatment of congestive heart failure
US5541110A (en)	1994-05-17	1996-07-30	Bristol-Myers Squibb	Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
BR9506313A (pt)	1994-08-12	1997-08-05	Univ Washington	Formas de cadeia simples do quarteto de hormônio de glicoproteína
US6083725A (en)	1996-09-13	2000-07-04	Transkaryotic Therapies, Inc.	Tranfected human cells expressing human α-galactosidase A protein
US20050032211A1 (en)	1996-09-26	2005-02-10	Metabogal Ltd.	Cell/tissue culturing device, system and method
US6310183B1 (en)	1997-09-10	2001-10-30	Novo Nordisk A/S	Coagulation factor VIIa composition
US6103501A (en) *	1997-11-17	2000-08-15	Washington University	Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof
CN100480266C (zh) *	1998-10-16	2009-04-22	拜奥根Idec马萨诸塞公司	干扰素-β融合蛋白及用途
US6514729B1 (en)	1999-05-12	2003-02-04	Xencor, Inc.	Recombinant interferon-beta muteins
PE20010288A1 (es)	1999-07-02	2001-03-07	Hoffmann La Roche	Derivados de eritropoyetina
US20020127652A1 (en)	2000-02-11	2002-09-12	Schambye Hans Thalsgard	Follicle stimulating hormones
US7094566B2 (en) *	2000-03-16	2006-08-22	Amgen Inc.,	IL-17 receptor like molecules and uses thereof
WO2002036169A2 (en) *	2000-10-31	2002-05-10	Pr Pharmaceuticals, Inc.	Methods and compositions for enhanced delivery of bioactive molecules
DE60136958D1 (de)	2000-12-01	2009-01-22	Takeda Pharmaceutical	Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz
JP4409135B2 (ja) *	2000-12-01	2010-02-03	武田薬品工業株式会社	生理活性物質含有製剤の製造法
WO2002046227A2 (en) *	2000-12-07	2002-06-13	Eli Lilly And Company	Glp-1 fusion proteins
AU2002222740A1 (en) *	2000-12-11	2002-06-24	Cheil Jedang Corporation	Fusion protein having the enhanced in vivo activity of erythropoietin
KR101229995B1 (ko)	2000-12-11	2013-02-06	씨제이 주식회사	생체내 에리스로포이에틴 활성이 증진된 융합단백질
WO2002053136A1 (en)	2000-12-28	2002-07-11	Takeda Chemical Industries, Ltd.	Sustained release preparations
JP5160005B2 (ja) *	2000-12-28	2013-03-13	武田薬品工業株式会社	徐放性製剤
US6887462B2 (en)	2001-04-09	2005-05-03	Chiron Corporation	HSA-free formulations of interferon-beta
CN1512890A (zh) *	2001-04-25	2004-07-14	开米卡公司	Hcg制剂
US6824769B2 (en)	2001-08-28	2004-11-30	Vertex Pharmaceuticals Incorporated	Optimal compositions and methods thereof for treating HCV infections
GB0121709D0 (en)	2001-09-07	2001-10-31	Imp College Innovations Ltd	Food inhibition agent
CA2465007C (en) *	2001-10-29	2012-01-17	Crucell Holland B.V.	Methods and means for producing proteins with predetermined post-translational modifications
KR100511749B1 (ko) *	2001-11-06	2005-09-02	선바이오(주)	변형된 인터페론-베타, 및 이의 화학적으로 변형된 배합체
KR100467750B1 (ko) *	2001-11-29	2005-01-24	씨제이 주식회사	생체내 에리스로포이에틴 활성이 증진된 융합단백질
KR100467751B1 (ko) *	2001-12-03	2005-01-24	씨제이 주식회사	생체내 에리스로포이에틴 활성이 증진된 융합단백질
EP1997829A1 (en)	2001-12-21	2008-12-03	Human Genome Sciences, Inc.	Albumin fusion proteins
US7081446B2 (en)	2002-01-31	2006-07-25	The Trustees Of Columbia University In The City Of New York	Long-acting follicle stimulating hormone analogues and uses thereof
US7173113B2 (en)	2002-01-31	2007-02-06	The Trustees Of Columbia University In The City Of New York	Long-acting hormone and growth factor compositions and uses thereof
AU2003256603C1 (en) *	2002-07-17	2010-07-15	Biogen Idec Ma Inc.	Therapies for renal failure using interferon-Beta
US7459435B2 (en)	2002-08-29	2008-12-02	Hoffmann-La Roche Inc.	Treatment of disturbances of iron distribution
US7459436B2 (en)	2002-11-22	2008-12-02	Hoffmann-La Roche Inc.	Treatment of disturbances of iron distribution
JP4683319B2 (ja) *	2003-02-19	2011-05-18	武田薬品工業株式会社	徐放性製剤用の分散剤
WO2004073749A1 (ja)	2003-02-19	2004-09-02	Takeda Pharmaceutical Company Limited	徐放性製剤用の分散剤
US7649084B2 (en)	2003-11-12	2010-01-19	University Of Georgia Research Foundation, Inc.	Recombinant glycoproteins related to feline thyrotropin
DK1696947T3 (en)	2003-12-19	2014-03-17	Hoffmann La Roche	APPLICATION OF ERYTHROPOIETIN IN THE TREATMENT OF DISORDERS OF THE IRON DISTRIBUTION IN CHRONIC INFLAMMATORY INTESTINAL DISEASES
ES2357132T3 (es)	2004-03-19	2011-04-19	Baxter International Inc.	Factor ixa para el tratamiento de trastornos hemorrágicos.
ATE469216T1 (de)	2004-08-17	2010-06-15	Csl Behring Gmbh	Modifizierte vitamin-k-abhängige polypeptide
EP1728798A1 (en)	2005-06-01	2006-12-06	ZLB Behring GmbH	Coagulation factor X polypeptides with modified activation properties
US8304386B2 (en)	2006-02-03	2012-11-06	Prolor Biotech, Inc.	Long-acting growth hormone and methods of producing same
US8048849B2 (en)	2006-02-03	2011-11-01	Modigene, Inc.	Long-acting polypeptides and methods of producing same
US7553940B2 (en) *	2006-02-03	2009-06-30	Modigene Inc	Long-acting EPO polypeptides and derivatives thereof and methods thereof
US8476234B2 (en)	2006-02-03	2013-07-02	Prolor Biotech Inc.	Long-acting coagulation factors and methods of producing same
US8048848B2 (en)	2006-02-03	2011-11-01	Prolor Biotech Ltd.	Long-acting interferons and derivatives thereof and methods thereof
US8450269B2 (en)	2006-02-03	2013-05-28	Prolor Biotech Ltd.	Long-acting growth hormone and methods of producing same

2007
- 2007-02-01 US US11/700,910 patent/US7553940B2/en active Active
- 2007-02-01 WO PCT/US2007/002767 patent/WO2007092252A2/en not_active Ceased
- 2007-02-01 US US11/700,911 patent/US7553941B2/en active Active
- 2007-02-05 AU AU2007215466A patent/AU2007215466C1/en active Active
- 2007-02-05 ES ES12150722.2T patent/ES2494792T3/es active Active
- 2007-02-05 SI SI200731509T patent/SI2471807T1/sl unknown
- 2007-02-05 SI SI200731450T patent/SI2001903T1/sl unknown
- 2007-02-05 SI SI200732145T patent/SI3202779T1/sl unknown
- 2007-02-05 KR KR1020147034884A patent/KR101651977B1/ko not_active Expired - Fee Related
- 2007-02-05 EP EP14197286.9A patent/EP2853536B1/en active Active
- 2007-02-05 ES ES14196333.0T patent/ES2663365T3/es active Active
- 2007-02-05 CN CN200780012026.6A patent/CN101595122B/zh not_active Expired - Fee Related
- 2007-02-05 CN CN201410213485.2A patent/CN104292340A/zh active Pending
- 2007-02-05 KR KR1020167010991A patent/KR101651978B1/ko not_active Expired - Fee Related
- 2007-02-05 EP EP12179821.9A patent/EP2532675B1/en active Active
- 2007-02-05 JP JP2008553393A patent/JP5905185B2/ja active Active
- 2007-02-05 US US11/702,156 patent/US20070184530A1/en not_active Abandoned
- 2007-02-05 CN CN201410214401.7A patent/CN104804096B/zh active Active
- 2007-02-05 DK DK12150722.2T patent/DK2471807T3/da active
- 2007-02-05 EP EP17161199.9A patent/EP3202779B1/en active Active
- 2007-02-05 EP EP19205364.3A patent/EP3663312A1/en not_active Withdrawn
- 2007-02-05 ES ES14197286.9T patent/ES2636668T3/es active Active
- 2007-02-05 KR KR1020147019160A patent/KR101636790B1/ko not_active Expired - Fee Related
- 2007-02-05 ES ES17161199T patent/ES2779650T3/es active Active
- 2007-02-05 CA CA2641342A patent/CA2641342C/en active Active
- 2007-02-05 KR KR1020087021554A patent/KR101483723B1/ko active Active
- 2007-02-05 ES ES07749922.6T patent/ES2477390T3/es active Active
- 2007-02-05 HU HUE17161199A patent/HUE048307T2/hu unknown
- 2007-02-05 PT PT121507222T patent/PT2471807E/pt unknown
- 2007-02-05 WO PCT/US2007/003014 patent/WO2007094985A2/en not_active Ceased
- 2007-02-05 DK DK07749922.6T patent/DK2001903T3/da active
- 2007-02-05 PL PL12150722T patent/PL2471807T3/pl unknown
- 2007-02-05 EP EP12150722.2A patent/EP2471807B1/en active Active
- 2007-02-05 CA CA2874280A patent/CA2874280A1/en not_active Abandoned
- 2007-02-05 PT PT171611999T patent/PT3202779T/pt unknown
- 2007-02-05 DK DK17161199.9T patent/DK3202779T3/da active
- 2007-02-05 EP EP12179805.2A patent/EP2532674B1/en active Active
- 2007-02-05 PL PL17161199T patent/PL3202779T3/pl unknown
- 2007-02-05 KR KR1020167022989A patent/KR101708730B1/ko active Active
- 2007-02-05 EP EP07749922.6A patent/EP2001903B1/en active Active
- 2007-02-05 EP EP14196333.0A patent/EP2853541B1/en active Active
2008
- 2008-07-31 IL IL193198A patent/IL193198A/en active IP Right Grant
2009
- 2009-03-11 US US12/401,755 patent/US8114836B2/en active Active
- 2009-03-11 US US12/401,737 patent/US8110376B2/en active Active
- 2009-03-11 US US12/401,746 patent/US8097435B2/en active Active
2011
- 2011-07-28 US US13/192,542 patent/US8465948B2/en active Active
2014
- 2014-04-24 IL IL232248A patent/IL232248A/en not_active IP Right Cessation
2015
- 2015-05-11 JP JP2015096578A patent/JP2015155458A/ja not_active Withdrawn
- 2015-05-11 JP JP2015096615A patent/JP6333214B2/ja not_active Expired - Fee Related
- 2015-05-11 JP JP2015096597A patent/JP6188741B2/ja not_active Expired - Fee Related
- 2015-07-09 HK HK15106570.8A patent/HK1205945A1/xx unknown
- 2015-12-18 JP JP2015247398A patent/JP6182200B2/ja active Active
2016
- 2016-05-31 IL IL245954A patent/IL245954A0/en unknown
2017
- 2017-02-23 IL IL250745A patent/IL250745B/en active IP Right Grant
2019
- 2019-02-21 IL IL264957A patent/IL264957B/en active IP Right Grant

Also Published As

Publication number	Publication date
WO2007092252A2 (en)	2007-08-16
SI2001903T1 (sl)	2014-09-30
EP3202779A2 (en)	2017-08-09
CN104804096B (zh)	2018-04-13
IL264957B (en)	2021-05-31
AU2007215466A1 (en)	2007-08-23
US20090270489A1 (en)	2009-10-29
EP2532675B1 (en)	2015-09-02
US20090275084A1 (en)	2009-11-05
WO2007092252A3 (en)	2008-04-10
EP2001903B1 (en)	2014-01-29
IL250745B (en)	2019-02-28
KR101651978B1 (ko)	2016-08-29
JP2016053084A (ja)	2016-04-14
US7553941B2 (en)	2009-06-30
US8097435B2 (en)	2012-01-17
DK2471807T3 (da)	2014-09-01
IL232248A0 (en)	2014-06-30
EP2532674B1 (en)	2015-09-09
JP6188741B2 (ja)	2017-08-30
KR20150014962A (ko)	2015-02-09
PT3202779T (pt)	2020-05-04
JP2015178512A (ja)	2015-10-08
CA2641342C (en)	2018-06-05
KR101708730B1 (ko)	2017-02-21
AU2007215466C1 (en)	2013-08-29
JP2015147800A (ja)	2015-08-20
EP2532675A1 (en)	2012-12-12
SI2471807T1 (sl)	2014-11-28
EP2001903A2 (en)	2008-12-17
JP2015155458A (ja)	2015-08-27
EP2471807B1 (en)	2014-06-25
US20070184530A1 (en)	2007-08-09
JP2009525052A (ja)	2009-07-09
CA2641342A1 (en)	2007-08-23
IL193198A0 (en)	2011-08-01
EP3663312A1 (en)	2020-06-10
JP5905185B2 (ja)	2016-04-20
CN104292340A (zh)	2015-01-21
KR20080093148A (ko)	2008-10-20
IL245954A0 (en)	2016-07-31
EP2471807A1 (en)	2012-07-04
EP2853536A1 (en)	2015-04-01
IL232248A (en)	2017-03-30
WO2007094985A2 (en)	2007-08-23
CN101595122B (zh)	2014-06-25
US20070190611A1 (en)	2007-08-16
US20090286733A1 (en)	2009-11-19
EP2853541B1 (en)	2017-12-13
JP6182200B2 (ja)	2017-08-16
EP3202779A3 (en)	2017-09-06
US20120004286A1 (en)	2012-01-05
JP6333214B2 (ja)	2018-05-30
WO2007094985A3 (en)	2009-04-16
ES2477390T3 (es)	2014-07-16
SI3202779T1 (sl)	2020-06-30
US8110376B2 (en)	2012-02-07
PL2471807T3 (pl)	2014-12-31
PT2471807E (pt)	2014-09-03
DK3202779T3 (da)	2020-03-09
CN104804096A (zh)	2015-07-29
HK1205945A1 (en)	2015-12-31
ES2494792T3 (es)	2014-09-16
US8114836B2 (en)	2012-02-14
CA2874280A1 (en)	2007-08-23
EP2853536B1 (en)	2017-05-03
CN101595122A (zh)	2009-12-02
HUE048307T2 (hu)	2020-07-28
US8465948B2 (en)	2013-06-18
HK1138854A1 (en)	2010-09-03
KR101651977B1 (ko)	2016-08-29
IL250745A0 (en)	2017-04-30
EP2532674A1 (en)	2012-12-12
KR20140094656A (ko)	2014-07-30
DK2001903T3 (da)	2014-05-05
ES2636668T3 (es)	2017-10-06
EP3202779B1 (en)	2019-12-04
ES2779650T3 (es)	2020-08-18
EP2853541A1 (en)	2015-04-01
KR101483723B1 (ko)	2015-01-26
KR20160052787A (ko)	2016-05-12
ES2663365T3 (es)	2018-04-12
KR101636790B1 (ko)	2016-07-07
EP2001903A4 (en)	2009-11-11
US20070190610A1 (en)	2007-08-16
HK1212715A1 (zh)	2016-06-17
KR20160103176A (ko)	2016-08-31
US7553940B2 (en)	2009-06-30
IL193198A (en)	2014-05-28

Publication	Publication Date	Title
SI3202779T1 (sl)	2020-06-30	Dolgo delujoči polipeptidi rastnega hormona HGH in njihova uporaba
ZA200901280B (en)	2010-02-24	Exendin fusion proteins
ZA200810738B (en)	2018-11-28	Polypeptide
IL237314A0 (en)	2015-04-30	Modified insulin polypeptides and their uses
IL196889A0 (en)	2011-08-01	Albumin-insulin fusion proteins
EP2048861A4 (en)	2010-09-08	PORTABLE DEVICE
GB0524788D0 (en)	2006-01-11	Polypeptides
GB0708376D0 (en)	2007-06-06	Novel polypeptides and uses thereof
IL193700A0 (en)	2011-08-01	Medicaments and proteins
EP1976864A4 (en)	2010-09-01	NEW PEPTIDE AND ITS USE
PL2046830T3 (pl)	2011-11-30	Polipeptydy CSF3R i ich zastosowania
EP1979827A4 (en)	2010-12-01	METHOD OF INTERACTING WITH A USER AND TERMINAL THEREOF
GB0611116D0 (en)	2006-07-19	Proteins
IL195525A0 (en)	2011-08-01	Replikin peptides and uses thereof
IL194786A0 (en)	2011-08-01	Methods and compositions relating to zpa polypeptides
GB0615635D0 (en)	2006-09-13	Immunogenic proteins and uses thereof
GB0621513D0 (en)	2006-12-06	Novel polypeptides and uses thereof
GB0607798D0 (en)	2006-05-31	Novel polypeptides and use thereof
GB0601976D0 (en)	2006-03-15	Proteins
GB0604187D0 (en)	2006-04-12	Peptide and uses thereof
GB0620735D0 (en)	2006-11-29	Proteins
SI2032708T1 (sl)	2014-11-28	Rekombinantni novirabdovirusi in njihove uporabe
GB0505949D0 (en)	2005-04-27	Polypeptides
GB0623539D0 (en)	2007-01-03	Polypeptides
GB2434383B (en)	2008-07-09	Windproof larch lap fencing